IMIPENEM/CILASTATIN/ RELEBACTAM (Recarbrio®)

Clinical Indication

Aerobic Gram-negative infections

Date of classification

October 2020

Review date

July 2021

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.